"JPM26: SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody" was originally created and published by ...

Given the multifaceted nature of ADCs, developers should have an integrated analytical toolkit. Three complementary approaches dominate the current landscape: Ligand Binding Assays (LBA): Ideal for ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

The company’s first-in-class and potential best-in-class therapeutics promise to be both effective and organ-protective and ...

Higher levels of antimitochondrial antibodies in patients with systemic lupus erythematosus are tied to a higher risk for ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...